Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy
Rhea-AI Summary
Profusa (NASDAQ: PFSA), a commercial stage digital health company, has announced its initial $1 million investment in Bitcoin (BTC) as part of its digital asset treasury strategy. The company has partnered with BlockFills, a global crypto trading solutions provider, to execute its BTC treasury management strategy.
The investment represents Profusa's strategic move to hedge against macroeconomic uncertainties, reflecting its conviction in Bitcoin as a digital store of value. The company is collaborating with Ascent Partners Fund to establish a cost-efficient Bitcoin treasury strategy while maintaining sufficient capital for its AI-driven digital health platform development.
Positive
- Strategic $1 million Bitcoin investment to hedge against macroeconomic uncertainties
- Partnership with established crypto trading solutions provider BlockFills
- Capital-efficient approach to digital asset treasury management
Negative
- Exposure to volatile cryptocurrency market risks
- Allocation of capital away from core digital health business
News Market Reaction
On the day this news was published, PFSA declined 17.80%, reflecting a significant negative market reaction. Argus tracked a trough of -9.3% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $6M from the company's valuation, bringing the market cap to $29M at that time.
Data tracked by StockTitan Argus on the day of publication.
BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces its initial
"It is important that we diligently execute on our digital treasury strategy designed to maximize our Bitcoin investment and maintain sufficient capital to provide the best-in-class, AI-driven digital health platform for the benefit of chronic disease and health and wellness management. These activities will help ensure that we are appropriately managing our resources and facilitating shareholder value. This initial investment is an important first step in our collaboration with Ascent Partners Fund to establish a low cost, capital efficient, best of breed, Bitcoin treasury strategy reflecting our strong conviction in Bitcoin as the digital store of value for the future and our dedication to driving our healthcare programs forward,” said Ben Hwang, Ph.D., Profusa’s Chairman and CEO.
About Profusa
Based in Berkeley, Calif., Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.
“LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.
For more information, visit https://profusa.com.
Special Note Regarding Forward-Looking Statements
Certain statements in this press release (this “Press Release”) may be considered “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of Profusa or the combined company. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “propose,” “seek,” “should,” “strive,” “will,” or “would” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which may be beyond the control of Profusa and could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including risks regarding the highly volatile nature of the price of Bitcoin and other cryptocurrencies, as well as the risk that the Company's stock price may be highly correlated to the price of the digital assets that it holds. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Profusa and its management are inherently uncertain. Profusa cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. There are risks and uncertainties described in the definitive proxy/final prospectus relating to the business combination, which has been filed with the SEC, and described in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.
Contacts
Investor and Media Contacts
email: info@coreir.com
phone: 1 (212) 655-0924
FAQ
How much did Profusa (PFSA) invest in Bitcoin in July 2025?
Who is Profusa partnering with for its Bitcoin treasury management?
Why is Profusa (PFSA) investing in Bitcoin?
What is Profusa's core business?
Will Profusa make additional Bitcoin investments?
